CDC2-like kinase inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CDC2-like kinase inhibitor, covering 2025-12-22 to 2025-12-22. Get the full timeline:
Most recent: Clinical Trial Update: Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial) [Phase 1, Phase 2]